You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
Directing lab-developed tests through the emergency use authorization process has brought to light reagent supply shortages and other hurdles.
Genomica, a PharmaMar Group company, has developed kits based on real-time PCR and its CLART low-density microarray technology.
Hologic said laboratories may leverage the random-access and open-access capabilities of its Panther Fusion system to broaden screening for the novel coronavirus.
LabCorp's test is being made available pursuant to FDA guidance that allows high-complexity, CLIA-certified labs to perform their own tests for SARS-CoV-2.
Some believe that more could be done to help deliver diagnostics to the European market.
A*STAR and Tan Tock Seng Hospital developed the test, which is the first diagnostic to be deployed in the country's hospitals since the outbreak began in December.
The company said its Liberty16 device is capable of detecting viral infection quickly, and can be deployed where other PCR instruments are too big to go.
The single-tube real-time PCR-based test has also received CE marking, according to Seegene, and is now commercially available.
The Centers for Disease Control and Prevention says one of the test reagents will likely need to be remanufactured in its labs.